The effects of omega-3 fatty acids supplementation on type 2 diabetes mellitus

Phase 2

• Conditions: Type 2 diabetes mellitus.; Non-insulin-dependent diabetes mellitus

• Registration Number: IRCT2017092724081N3
• Lead Sponsor: Vice chancellor for research, Tehran University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 20

Inclusion Criteria

The criteria for inclusion were as follows: 30-65 years of age; T2DM diagnosis; and BMI in the range of 18.5 to 40 kg/m2. Patients with a history of diseases including chronic renal; hepatic; gastrointestinal; hematological diseases; and thyroid disorder as well as pregnant and lactating patients were excluded from the study. Furthermore, Patients who were treated with insulin; Thiazolidinediones or consumed weight loss drugs and any nutritional supplement 2 weeks prior to the beginning of the study were excluded from the study.
The exclusion criteria: Unwillingness to cooperate; change the dose or type of anti-diabetes drug; incidence of any sensitivity Interventions.

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Omentin. Timepoint: Pre-intervention/10 weeks after intervention. Method of measurement: ELISA - mg/dl.;Chemerin. Timepoint: Pre-intervention/10 weeks after intervention. Method of measurement: ELISA - mg/dl.;TNF-alpha. Timepoint: Pre-intervention/10 weeks after intervention. Method of measurement: ELISA - pg/dl.

Secondary Outcome Measures

Name	Time	Method
Insulin. Timepoint: Pre-intervention/10 weeks after intervention. Method of measurement: ELISA/µIU/ml.;HOMA-IR. Timepoint: Pre-intervention/10 weeks after intervention. Method of measurement: fasting insulin (µIU/ml) × fasting glucose (mmol/ml)/22.5.;QUICKI. Timepoint: Pre-intervention/10 weeks after intervention. Method of measurement: 1/{log[fasting insulin (µU/mL)] + log[fasting glucose (mg/dL)].